|
Volumn 21, Issue 2 S, 1986, Pages 109S-121S
|
The mechanism of action of calcium antagonists relative to their clinical applications.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEPRIDIL;
CALCIUM ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
CINNARIZINE;
DILTIAZEM;
FELODIPINE;
FLUNARIZINE;
GALLOPAMIL;
LIDOFLAZINE;
NICARDIPINE;
NIFEDIPINE;
NILUDIPINE;
NIMODIPINE;
NISOLDIPINE;
NITRENDIPINE;
PERHEXILINE;
PIPERAZINE DERIVATIVE;
TIAPAMIL;
VERAPAMIL;
ANGINA PECTORIS;
CARDIOVASCULAR SYSTEM;
DRUG THERAPY;
HEART;
HEART ARRHYTHMIA;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
PERIPHERAL VASCULAR SYSTEM;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
THERAPY;
ANIMAL;
CALCIUM CHANNEL BLOCKERS;
CARDIOVASCULAR DISEASES;
HUMAN;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
|
EID: 0022969680
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.1986.tb02860.x Document Type: Article |
Times cited : (85)
|
References (22)
|